| Symbol |
Name |
|
ACO1
|
aconitase 1, soluble
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
ATF6
|
activating transcription factor 6
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
CA9
|
carbonic anhydrase IX
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CDC6
|
cell division cycle 6
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
E4F1
|
E4F transcription factor 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
GNB5
|
guanine nucleotide binding protein (G protein), beta 5
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GTF2F2
|
general transcription factor IIF, polypeptide 2, 30kDa
|
|
HDAC1
|
histone deacetylase 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL32
|
interleukin 32
|
|
IL6
|
interleukin 6
|
|
IRF3
|
interferon regulatory factor 3
|
|
JAK2
|
Janus kinase 2
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MIA2
|
melanoma inhibitory activity 2
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR122
|
microRNA 122
|
|
MIR125A
|
microRNA 125a
|
|
MIR132
|
microRNA 132
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR192
|
microRNA 192
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR373
|
microRNA 373
|
|
MIR520B
|
microRNA 520b
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTA1
|
metastasis associated 1
|
|
MTDH
|
metadherin
|
|
MUTYH
|
mutY homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
PAPD4
|
PAP associated domain containing 4
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
POLR2E
|
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RHOC
|
ras homolog family member C
|
|
RPS3A
|
ribosomal protein S3A
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TP53
|
tumor protein p53
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
URGCP
|
upregulator of cell proliferation
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
XBP1
|
X-box binding protein 1
|
